Back
Janux Therapeutics Vs. Syndax Pharmaceuticals Industry Stock Comparison
Sell
34
JANX
Janux Therapeutics
Last Price:
50.18
Seasonality Move:
-11.26%
Sell
40
SNDX
Syndax Pharmaceuticals
Last Price:
18.24
Seasonality Move:
-8.74%
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $50.03. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Syndax Pharmaceuticals (SNDX)
is a Sell
Is Syndax Pharmaceuticals a Buy, Sell or Hold?
- The current Syndax Pharmaceuticals [SNDX] share price is $18.63. The Score for SNDX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- SNDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $50.03
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing slight buying pressure.
SNDX Stock Price Chart
What is Syndax Pharmaceuticals's stock price today?
-
The Syndax Pharmaceuticals share price today is $18.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNDX is experiencing slight buying pressure.
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.8 | Buy |
| Relative Strength Index (14 RSI): | 62.28 | Buy |
| Chaikin Money Flow: | 141306 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.74 - 47.92) | Buy |
| Bollinger Bands (100): | (39.33 - 50.89) | Buy |
SNDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.68 | Sell |
| Relative Strength Index (14 RSI): | 41.97 | Sell |
| Chaikin Money Flow: | 473332 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.62 - 20.58) | Sell |
| Bollinger Bands (100): | (19.16 - 22.32) | Sell |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.92 | Buy |
| 20-day SMA: | 45.86 | Buy |
| 50-day SMA: | 43.34 | Buy |
| 200-day SMA: | 34.63 | Buy |
| 8-day EMA: | 48.05 | Buy |
| 20-day EMA: | 46.01 | Buy |
| 50-day EMA: | 44.23 | Buy |
| 200-day EMA: | 36.24 | Buy |
SNDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.39 | Buy |
| 20-day SMA: | 19.44 | Sell |
| 50-day SMA: | 20.88 | Sell |
| 200-day SMA: | 21.19 | Sell |
| 8-day EMA: | 18.53 | Buy |
| 20-day EMA: | 19.18 | Sell |
| 50-day EMA: | 20.08 | Sell |
| 200-day EMA: | 20.56 | Sell |
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.19 per share, and a decrease next year of $0.46 per share.
Syndax Pharmaceuticals Earnings Growth & SNDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.34 per share, an increase next quarter of $0.24 per share, a decrease this year of $0.79 per share, and an increase next year of $0.54 per share.
Janux Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Syndax Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||